Authors
The end of 2010 was a rather bad time to be a spammer. Thanks to an industry-wide effort that included botnet takedowns and legal cases, we saw a dramatic shift in the way spammers used unsolicited e-mail to make money. In this Lab Matters webcast, Kaspersky Lab senior spam analyst Maria Namestnikova looks closely at the pharmaceutical spam operations and discusses how spammers are using affiliate programs and rebuilt botnets to recover from last year’s crackdown.
Authors
From the same authors
In the same category
Lab Matters – The State of Spam